TRAVASOL INJ WITHOUT ELECTROLYTES 5.5%
TRAVASOL INJ WITHOUT ELECTROLYTES 5.5%
Discontinued
DIN Number
00388742
Drug Class
Human
Market Date
Dec 31, 1978
Company
HC
baxter corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00388742
AIG Number1414586005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05BA01 AMINO ACIDS
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification40:20.00
Health Canada Classification
ACTIVE INGREDIENTS (14)
ARGININEActive
Strength: 570 MG / 100 ML
Monograph: ARGININE
GLYCINEActive
Strength: 1.14 G / 100 ML
Monograph: GLYCINE
HISTIDINEActive
Strength: 241 MG / 100 ML
Monograph: HISTIDINE
ISOLEUCINEActive
Strength: 263 MG / 100 ML
Monograph: ISOLEUCINE
L-ALANINEActive
Strength: 1.14 G / 100 ML
Monograph: L-ALANINE
L-LYSINE HYDROCHLORIDEActive
Strength: 318 MG / 100 ML
Monograph: L-LYSINE HYDROCHLORIDE
LEUCINEActive
Strength: 340 MG / 100 ML
Monograph: LEUCINE
METHIONINEActive
Strength: 318 MG / 100 ML
Monograph: METHIONINE
PHENYLALANINEActive
Strength: 340 MG / 100 ML
Monograph: PHENYLALANINE
PROLINEActive
Strength: 230 MG / 100 ML
Monograph: PROLINE
THREONINEActive
Strength: 230 MG / 100 ML
Monograph: THREONINE
TRYPTOPHANActive
Strength: 99 MG / 100 ML
Monograph: TRYPTOPHAN
TYROSINEActive
Strength: 22 MG / 100 ML
Monograph: TYROSINE
VALINEActive
Strength: 252 MG / 100 ML
Monograph: VALINE